ArticleCureus2025

An Observational Study of Glycopegylated Extended Half-Life Factor Prophylaxis in Hemophilia A and B in a Tertiary Care Center in India.

Parul Bhatt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.